Pacific Biosciences Of California reported $61.01M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Accelerate Diagnostics AXDX:US 8.21M 1.27M
Agilent A:US $ 1813M 229M
Bruker BRKR:US $ 880.5M 58M
Danaher DHR:US $ 7547M 593M
Fluidigm FLDM:US $ 47.17M 2.4M
General Electric GE:US 53.34B 1.39B
Illumina ILMN:US $ 1490M 397M
Myriad Genetics MYGN:US $ 166M 38.3M
Nanostring Technologies NSTG:US $ 49.59M 2.57M
Pacific Biosciences Of California PACB:US $ 61.01M 10.7M
Perkinelmer PKI:US $ 1263.05M 49.31M
Quidel QDEL:US $ 492.66M 169.14M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Waters WAT:US $ 687.83M 7.32M